AMERSHAM, England & MALVERN, Pa.--(BUSINESS WIRE)--Phlexglobal, pioneers and leaders in the provision of Trial Master File (TMF) technology and services for the global life sciences industry will be attending J.P. Morgan’s 34th Annual Healthcare Conference in San Francisco, January 11 to 14th, 2016.
Phlexglobal’s CEO Rick Riegel and Chairman Steve Kent will be meeting with healthcare companies attending this premier conference to champion the company’s innovative services and software solutions, including its best of breed eTMF technology PhlexEview. Attendees will be enlightened on the many advantages of an electronic solution for the collection of essential documents which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.
Phlexglobal is committed to developing superior systems and services for the TMF market to expedite study start up, facilitate regulatory inspection readiness, improve management and oversight and reduce costs.
For further information or to meet with Rick and Steve, please contact: investorrelations@phlexglobal.com
About Phlexglobal
Phlexglobal is a specialist provider of technology-enabled Trial Master File (TMF) solutions and services. Offering a unique combination of clinical trial knowledge, document management skills, regulatory understanding and technical expertise, they deliver a range of flexible, targeted solutions to meet business needs.
More information can be found at http://www.phlexglobal.com
